Intrinsic value of Avalo Therapeutics, Inc. (AVTX)
Live fair value data for Avalo Therapeutics, Inc. (AVTX) is currently unavailable. Please check again shortly.
Current Price: $333.00
Valuation: Undervalued
Confidence: 8.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Avalo Therapeutics, Inc. (AVTX) undervalued or overvalued?
Based on the current model output, Avalo Therapeutics, Inc. appears to be undervalued with a upside of 36.00%.
Fair value vs market price — Avalo Therapeutics, Inc. (AVTX)
Unlock premium access to view the live fair value comparison against current market price for AVTX.
Frequently Asked Questions - AVTX
How is AVTX intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for AVTX.
Is AVTX undervalued or overvalued right now?
AVTX is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for AVTX: open their intrinsic value pages.